GgoogleFR first seen 4 d ago, last 4 d ago, peak #2
New Phase 2 Data on Bezisterim for Long COVID
Original: covid long
New Phase 2 trial data has been released on Bezisterim as a potential treatment for long COVID, according to Psychiatric Times. The drug, an anti-inflammatory compound, is being studied for patients suffering from persistent symptoms after coronavirus infection. The findings are drawing attention as treatment options for long COVID remain limited and demand for effective therapies continues to grow.
Why now: People are searching for updates on long COVID treatments as new clinical trial data emerges.
Bezisterimlong COVIDPsychiatric Times
Evidence
- New Phase 2 Data on Bezisterim for the Treatment of Long COVID · Psychiatric Times
API: https://socialmediatrends-api.osmike.com/v1/trends/2887711